Navigation Links
Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
Date:6/9/2009

of type 2 diabetes, and has the advantage of inhibiting a novel drug target that differentiates it from currently marketed diabetes medications. With this promising drug profile, AR9281 has the potential to provide safe and effective therapy for patients with type 2 diabetes either as monotherapy or in combination with existing treatment regimens.

About Arete Therapeutics Inc.

Arete Therapeutics is a privately-held biotechnology company dedicated to the discovery and development of novel drugs to treat type 2 diabetes, hypertension and inflammatory disorders. It is the world's leading company focused on sEH, an important enzyme for the metabolism of arachidonic acid that plays an essential role in metabolic, inflammatory and cardiovascular physiology. The Company has raised a total of over $51 million in Series A financing led by Frazier Healthcare Ventures, Alta Partners, Three Arch Partners, Burrill & Company and Altitude Life Science Ventures. For more information on Arete Therapeutics, please visit www.aretetherapeutics.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

JAMES SABRY

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87722


'/>"/>
SOURCE Arete Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence
2. CareTech Solutions Launches Robust Service Desk Solution to Support Clinical Applications and Technology within Continuum Health Partners Hospitals
3. CareTech Solutions Caps Banner Year by Signing Pennsylvanias Lehigh Valley Health Network, Tennessees Covenant Health, and Ohios Marietta Memorial Hospital to Provide Web Services
4. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
5. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
6. CareTech Solutions Named Best in KLAS for Extensive IT Outsourcing Services
7. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
8. CareTech Solutions Service Desk Equals Help Desk Plus
9. Arete Therapeutics Appoints Donald Santel to Board of Directors
10. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
11. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ch firm Replikins Ltd. today issued its latest bio... It shows that the lethality of the virus has drop...us,s current outbreak in the spring of 2009 to res...1). The H1N1 infectivity count, however, remains i...) November 27, 2009 -- Biotech firm Replikins Ltd....
(Date:11/27/2009)...v. 27 Preventing diseas...rtunately every year, new vaccines are being added...nes boost immunity for the same period of time? An...ded to keep immunity strong? ,, In this month...n Academy of Pediatrics, Michael Pichichero MD, Di...
(Date:11/27/2009)...are Holdings has announced that it has become a na... the largest nonprofit organizations dedicated to ... Delray Beach, FL (Vocus) ...B: XCHO), a company specializing in the marketing ...ducts, has announced today that is has become a na...
(Date:11/27/2009)...TTLE, Nov. 27 Allrecipes.com , ...nksgiving traffic numbers, with more than 2.8 mill...g a clear picture of what was served on the bigges...ng meal in 2009 weighed in at 2,225 calories per s...t. According to the Allrecipes site, Sweet Potato...
(Date:11/27/2009)...alist manufacturers who use medical load cells at ... dollars by bringing in technology partner Flintec...f pro-active medical manufacturers are calling in ...their projects, ensuring that progress will not be...tially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...a,s Baby Boomers and Seniors Are Target Audiences ...EJO, Calif., Feb. 4 Bausch & Lomb, the global...vertising campaign has been launched in six Florid...rystalens, which is a product of Bausch & Lomb...
...SHINGTON, Feb. 4 "Patients, nurses, and the Broad...n to move into Ashburn was,denied," said Kathy McG...,Association/National Nurses Organizing Committee,...re,in the name of profits, and of shortchanging th...
... Solid 30 Percent Year-Over-Year...ve Strong 2008 Year End Results , ...9 -- Despite an economic environment that has prov...e the current economic environment, Lumension Se...
... A new website that displays a w...Spanish speakers to strawberries produced to Bigfo...prises. , Washington, DC ... whole new way, launched today. , ,From Spanish sp...
... Reid Supply Company,s President...esigned and improved company web site, as well as ...al products catalog. Both ReidSupply.com and the c...8, Reid Supply focuses on enhancing the Customer e...
...UIS, Feb. 3 Ther-Rx Corporation, a subsidiary of ...uing a voluntary nationwide recall of prescription...tified below (all lots within their expiration dat...ons that did not sufficiently comply with current ...
Other Medicine News:Health News:Bausch & Lomb's Crystalens to be Featured in Florida Advertising Campaign. 2Health News:Bausch & Lomb's Crystalens to be Featured in Florida Advertising Campaign. 3Health News:Lumension Expands Global Footprint, Extends Leadership in Endpoint Security and Unveils New Brand Identity 2Health News:Lumension Expands Global Footprint, Extends Leadership in Endpoint Security and Unveils New Brand Identity 3Health News:Lumension Expands Global Footprint, Extends Leadership in Endpoint Security and Unveils New Brand Identity 4Health News:Lumension Expands Global Footprint, Extends Leadership in Endpoint Security and Unveils New Brand Identity 5Health News:SHOWUSA Launches: New Website Showcases Animated Maps of U.S. Facts and Figures 2Health News:New Enhanced Web Site and Catalog from Reid Supply 2Health News:New Enhanced Web Site and Catalog from Reid Supply 3Health News:Ther-Rx Corporation Issues Voluntary Nationwide Recall of Prescription Prenatal and Iron Supplements to Wholesale Level 2
(Date:11/25/2009)... , CHAPEL HILL, N.C., Nov. 25 /PRNewswire/ -... Prabhavathi Fernandes, president and chief execut...t Annual Health Care Conference at 8:50 a.m. EST, ...New York City. Dr. Fernandes will provide an over...cal programs for the treatment of drug-resistant p...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repor...eport is available in its catalogue: ,, Intran...is http://www.reportlinker.com/p0164267/Intranas... ,, The US intranasal drug delivery market is ...s from the delivery of conventional local therapeu...
(Date:11/25/2009)... , FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /PRNe... (Nasdaq: HTWR ; ASX: HIN), a leading innovator a...tory support technologies revolutionizing the trea...hat it is scheduled to make an investor presentati...nference at 8:00 am EST on Wednesday, December 2, ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2New Bisphenol a Study Has Many Limitations but No Clear Conclusions 58912 1New Bisphenol a Study Has Many Limitations but No Clear Conclusions 58912 2New Bisphenol a Study Has Many Limitations but No Clear Conclusions 58912 3News briefs from the October issue of Chest 58908 1News briefs from the October issue of Chest 58908 2HEAL Africas Founders Conduct Nationwide Tour to Share Best Practices for Rebuilding Congo 58904 1HEAL Africas Founders Conduct Nationwide Tour to Share Best Practices for Rebuilding Congo 58904 2HEAL Africas Founders Conduct Nationwide Tour to Share Best Practices for Rebuilding Congo 58904 3
...ain, Sept. 25 Five-year follow-up overall,surviva...ncer Trial) study,show that oral chemotherapy Xelo...t standard treatment - intravenous bolus 5-FU/LV (...tment of Dukes, C colon cancer. These,data were pr...ce (ECCO) in,Barcelona, Spain. Results show five-...
... Hearing Loss Program With Novel SiRNA Approaches ...g Candidate, AHLI-11, For The, Prevention Of Che...ge, FREMONT, Calif., Sept. 24 Quark Pharmaceutic...ny focused on discovering and,developing novel RNA...that,it has signed a collaboration agreement with ...
Other Medicine Technology:Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting 2Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting 3Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting 4Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss 2Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss 3
Adson Bone Rongeurs
Rongeur #18
Rongeur #4
Schell Rongeur
Medicine Products: